Paul O’Donohoe

757 total citations
18 papers, 499 citations indexed

About

Paul O’Donohoe is a scholar working on Economics and Econometrics, General Health Professions and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Paul O’Donohoe has authored 18 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Economics and Econometrics, 5 papers in General Health Professions and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Paul O’Donohoe's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Delphi Technique in Research (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). Paul O’Donohoe is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Delphi Technique in Research (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). Paul O’Donohoe collaborates with scholars based in United States, United Kingdom and Germany. Paul O’Donohoe's co-authors include Stephen Joel Coons, Helen Doll, Willie Muehlhausen, D Wild, J. Jason Lundy, Sonya Eremenco, Bill Byrom, Mabel Crescioni, Marie Mc Carthy and Rachel Ballinger and has published in prestigious journals such as BMC Psychiatry, Health and Quality of Life Outcomes and Value in Health.

In The Last Decade

Paul O’Donohoe

18 papers receiving 482 citations

Peers

Countries citing papers authored by Paul O’Donohoe

Since Specialization

Citations

This map shows the geographic impact of Paul O’Donohoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul O’Donohoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul O’Donohoe more than expected).

Fields of papers citing papers by Paul O’Donohoe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul O’Donohoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul O’Donohoe. The network helps show where Paul O’Donohoe may publish in the future.

Co-authorship network of co-authors of Paul O’Donohoe

This figure shows the co-authorship network connecting the top 25 collaborators of Paul O’Donohoe. A scholar is included among the top collaborators of Paul O’Donohoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul O’Donohoe. Paul O’Donohoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Best Practices for the Electronic Implementation and Migration of Patient-Reported Outcome Measures 2023 ·Value in Health ·Florence D. Mowlem, Celeste A. Elash, Kelly M. Dumais, (unknown), Paul O’Donohoe, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	6
2	Updated Recommendations on Evidence Needed to Support Measurement Comparability Among Modes of Data Collection for Patient-Reported Outcome Measures: A Good Practices Report of an ISPOR Task Force 2023 ·Value in Health ·Paul O’Donohoe, David S. Reasner, (unknown), Bill Byrom, Sonya Eremenco, Alexandra I. Barsdorf, (unknown), Stephen Joel Coons	10
3	Comparability of a provisioned device versus bring your own device for completion of patient-reported outcome measures by participants with chronic obstructive pulmonary disease: quantitative study findings 2022 ·Journal of Patient-Reported Outcomes ·Stacie Hudgens, Louise Newton, Sonya Eremenco, Mabel Crescioni, Tara Symonds, (unknown), David S. Reasner, Bill Byrom, Paul O’Donohoe, Susan Vallow	5
4	Recommendations for the Electronic Migration and Implementation of Clinician-Reported Outcome Assessments in Clinical Trials 2022 ·Value in Health ·Heather Romero, (unknown), Paul O’Donohoe, Kathleen W. Wyrwich, (unknown), (unknown), Tom Willgoss, (unknown), Mabel Crescioni, Shelly Steele, (unknown)	4
5	Comparability of a provisioned device versus bring your own device for completion of patient-reported outcome measures by participants with chronic obstructive pulmonary disease: qualitative interview findings 2022 ·Journal of Patient-Reported Outcomes ·Louise Newton, (unknown), Sonya Eremenco, Stacie Hudgens, Mabel Crescioni, Tara Symonds, David S. Reasner, Bill Byrom, Paul O’Donohoe, Susan Vallow	4
6	PRS87 - COMPARABILITY OF A PROVISIONED DEVICE VERSUS BRING YOUR OWN DEVICE FOR COMPLETION OF PATIENT-REPORTED OUTCOME (PRO) MEASURES BY PARTICIPANTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): QUALITATIVE INTERVIEW FINDINGS 2018 ·Value in Health ·Louise Newton, (unknown), Sonya Eremenco, Stacie Hudgens, Mabel Crescioni, (unknown), David S. Reasner, Bill Byrom, Paul O’Donohoe, S. Vallow	1
7	Best Practices for Avoiding Paper Backup When Implementing Electronic Approaches to Patient-Reported Outcome Data Collection in Clinical Trials 2018 ·Therapeutic Innovation & Regulatory Science ·(unknown), Celeste A. Elash, Mabel Crescioni, Sonya Eremenco, Paul O’Donohoe, (unknown)	4
8	Selection of and Evidentiary Considerations for Wearable Devices and Their Measurements for Use in Regulatory Decision Making: Recommendations from the ePRO Consortium 2017 ·Value in Health ·Bill Byrom, Christopher Watson, Helen Doll, Stephen Joel Coons, Sonya Eremenco, Rachel Ballinger, Marie Mc Carthy, Mabel Crescioni, Paul O’Donohoe, (unknown)	53
9	Equivalence of electronic and paper administration of patient-reported outcome measures: a systematic review and meta-analysis of studies conducted between 2007 and 2013 2015 ·Health and Quality of Life Outcomes ·Willie Muehlhausen, Helen Doll, (unknown), (unknown), Paul O’Donohoe, (unknown), D Wild	183
10	“Bring Your Own Device” (BYOD): The Future of Field-Based Patient-Reported Outcome Data Collection in Clinical Trials? 2015 ·Therapeutic Innovation & Regulatory Science ·Chad Gwaltney, Stephen Joel Coons, Paul O’Donohoe, (unknown), (unknown), (unknown), (unknown)	26
11	Considerations for Requiring Subjects to Provide a Response to Electronic Patient-Reported Outcome Instruments 2015 ·Therapeutic Innovation & Regulatory Science ·Paul O’Donohoe, J. Jason Lundy, Ari Gnanasakthy, (unknown)	2
12	Capturing Patient-Reported Outcome (PRO) Data Electronically: The Past, Present, and Promise of ePRO Measurement in Clinical Trials 2014 ·Patient ·Stephen Joel Coons, (unknown), J. Jason Lundy, Paul O’Donohoe, (unknown), (unknown)	149
13	Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison 2014 ·BMC Psychiatry ·Tatiana Dilla, Jörgen Möller, Paul O’Donohoe, (unknown), José Antonio Sacristán, Michael Happich, (unknown)	13
14	A literature review of the variance in interval length between administrations for assessment of test retest reliability and equivalence of pro measures 2013 ·Value in Health ·(unknown), (unknown), (unknown), Willie Muehlhausen, Paul O’Donohoe	16
15	PMD61 Evaluating the Usability of an ePRO Diary for Measuring COPD Symptoms at Night and Early Morning 2012 ·Value in Health ·Sonya Eremenco, Andrew Palsgrove, Michelle Mocarski, Paul O’Donohoe, Asha Hareendran	2
16	PMH31 Cost-Effectiveness of Long-Acting Olanzapine Versus Long-Acting Risperidone in Patients with Schizophrenia in Spain 2011 ·Value in Health ·Tatiana Dilla, Paul O’Donohoe, Jörgen Möller, (unknown), José Antonio Sacristán, Luis San, Michael Happich, (unknown)	3
17	In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European retrospective observational chart review 2010 ·Reproductive Biology and Endocrinology ·Geoffrey Trew, (unknown), Samantha Gillard, (unknown), (unknown), Paul O’Donohoe, Radoslaw Wasiak	17
18	PMH42 COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE LONG-ACTING INJECTION COMPARED WITH RISPERIDONE LONG-ACTING INJECTION IN THE TREATMENT OF SCHIZOPHRENIA IN NORWAY 2009 ·Value in Health ·(unknown), (unknown), (unknown), Paul O’Donohoe, (unknown), (unknown), (unknown), Diego Novick	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact